» Authors » Osamu Yamaguchi

Osamu Yamaguchi

Explore the profile of Osamu Yamaguchi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 347
Citations 9913
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kubo T, Sugiura K, Tokita Y, Takano H, Takamisawa I, Takayama M, et al.
Heart . 2025 Mar; PMID: 40037766
Background: The Japanese Hypertrophic Cardiomyopathy Registry Study was designed to provide comprehensive, real-world insights into the clinical characteristics and management of hypertrophic cardiomyopathy (HCM) in Japan. Methods: This multicentre, prospective...
2.
Taira M, Kawakami H, Asagi Y, Nishimura K, Yamaguchi O
J Arrhythm . 2025 Jan; 41(1):e13210. PMID: 39817004
A video demonstration presents the retrieval of a dislodged leadless pacemaker using the double-snare technique. Sharing troubleshooting strategies in such cases is clinically important for managing rare pacemaker complications.
3.
Nishikawa T, Higaki A, Kurokawa K, Yoshimoto K, Horie R, Nakao Y, et al.
In Vivo . 2024 Dec; 39(1):375-380. PMID: 39740918
Background/aim: Imeglimin, a novel oral antidiabetic agent, was approved in 2021 for the treatment of type 2 diabetes mellitus (T2DM). Phase III clinical trials demonstrated its safety and efficacy in...
4.
Konishi R, Higaki A, Miyoshi T, Nishimura K, Ikeda S, Yamaguchi O
Oxf Med Case Reports . 2024 Dec; 2024(12):omae156. PMID: 39734689
An 82-year-old woman with a history of myocardial infarction presented with worsening effort angina. Coronary angiography (CAG) revealed 75% stenosis in the proximal left anterior descending artery (LAD), with intravascular...
5.
Fujisawa T, Kawakami H, Tamaki S, Miyazaki S, Akazawa Y, Miyoshi T, et al.
Heart Vessels . 2024 Dec; PMID: 39674957
The relationship between post-ablation excessive supraventricular ectopic activity (ESVEA), a new marker for new-onset atrial fibrillation (AF), and late AF recurrence is uncertain. We enrolled 469 patients with AF who...
6.
Miyoshi T, Shinozuka F, Honda T, Akazawa Y, Yamaguchi O
Cureus . 2024 Nov; 16(10):e72231. PMID: 39583506
A male in his seventies was admitted for a patent ductus arteriosus (PDA) closure. We planned a catheter-based closure but avoided pre-procedural contrast-enhanced CT due to his low estimated glomerular...
7.
Murakawa T, Ito J, Rusu M, Taneike M, Omiya S, Moncayo-Arlandi J, et al.
Cell Rep . 2024 Nov; 43(12):115001. PMID: 39580803
The accumulation of damaged mitochondria in the heart is associated with heart failure. Mitophagy is an autophagic degradation system that specifically targets damaged mitochondria. We have reported previously that Bcl2-like...
8.
Miyoshi T, Nishimura T, Hiasa Y, Izutani H, Yamaguchi O
Cureus . 2024 Oct; 16(9):e70399. PMID: 39473651
An Impella device (Abiomed, Inc., Danvers, Massachusetts, United States) is a useful percutaneous left ventricular assist device for patients with cardiogenic shock. However, there are cases in which patients are...
9.
Honda R, Akazawa Y, Inoue K, Higaki T, Yamaguchi O
Eur Heart J Case Rep . 2024 Oct; 8(10):ytae525. PMID: 39445105
Background: Rifampicin is a strong inducer of the hepatic cytochrome P450 (CYP) family and is known to interact with many clinical drugs. However, to our knowledge, no case of worsening...
10.
Inaba S, Ikeda S, Fujiwara Y, Sogabe K, Inoue K, Nogami N, et al.
Cureus . 2024 Oct; 16(9):e68749. PMID: 39371770
Objectives: Coronavirus disease 2019 (COVID-19) vaccination is highly recommended to prevent the onset and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Japan. However, the impact of...